Dorothee Kern’s path from basketball star to founder of billion-dollar biotech(s?); Five Prime Therapeutics hands the reins to Genentech vet
I assure you that I did not plan to do this. I wanted to write a little story about proteins and cancer, nuclear magnetic imaging and a scientist turned entrepeneur of billion-dollar biotechs. Maybe a touch on communist East Germany. A sprinkle on her (what I assumed had been) past life as a world-class athlete. I did not — would not — plan on writing a story about someone succeeding “on-the-court and off-the-court,” a story held together by what I assumed would have to be forced parallels between basketball and science.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.